Vanrenterghem Y - Search Results

1

Balancing efficacy and toxicity of kidney transplant immunosuppression.

Naesens M, Lerut E, Sarwal M, Van Damme B, Vanrenterghem Y, Kuypers DR. Naesens M, et al. Among authors: vanrenterghem y. Transplant Proc. 2009 Oct;41(8):3393-5. doi: 10.1016/j.transproceed.2009.09.017. Transplant Proc. 2009. PMID: 19857756

2

Role of immunosuppressive drugs in the development of tissue-invasive cytomegalovirus infection in renal transplant recipients.

Kuypers DR, Evenepoel P, Maes BD, Coosemans W, Pirenne J, Vanrenterghem YF. Kuypers DR, et al. Among authors: vanrenterghem yf. Transplant Proc. 2002 Jun;34(4):1164-70. doi: 10.1016/s0041-1345(02)02812-9. Transplant Proc. 2002. PMID: 12072305 No abstract available.

3

C3D deposition in peritubular capillaries indicates a variant of acute renal allograft rejection characterized by a worse clinical outcome.

Kuypers DR, Lerut E, Evenepoel P, Maes B, Vanrenterghem Y, Van Damme B. Kuypers DR, et al. Among authors: vanrenterghem y. Transplantation. 2003 Jul 15;76(1):102-8. doi: 10.1097/01.TP.0000069040.16457.06. Transplantation. 2003. PMID: 12865794

4

Prospective study on late consequences of subclinical non-compliance with immunosuppressive therapy in renal transplant patients.

Vlaminck H, Maes B, Evers G, Verbeke G, Lerut E, Van Damme B, Vanrenterghem Y. Vlaminck H, et al. Among authors: vanrenterghem y. Am J Transplant. 2004 Sep;4(9):1509-13. doi: 10.1111/j.1600-6143.2004.00537.x. Am J Transplant. 2004. PMID: 15307839 Free article.

5

Multidrug resistance protein 2 genetic polymorphisms influence mycophenolic acid exposure in renal allograft recipients.

Naesens M, Kuypers DR, Verbeke K, Vanrenterghem Y. Naesens M, et al. Among authors: vanrenterghem y. Transplantation. 2006 Oct 27;82(8):1074-84. doi: 10.1097/01.tp.0000235533.29300.e7. Transplantation. 2006. PMID: 17060857

6

Acute rejection in non-compliant renal allograft recipients: a distinct morphology.

Lerut E, Kuypers DR, Verbeken E, Cleutjens J, Vlaminck H, Vanrenterghem Y, Van Damme B. Lerut E, et al. Among authors: vanrenterghem y. Clin Transplant. 2007 May-Jun;21(3):344-51. doi: 10.1111/j.1399-0012.2007.00647.x. Clin Transplant. 2007. PMID: 17488383

7

Subclinical peritubular capillaritis at 3 months is associated with chronic rejection at 1 year.

Lerut E, Naesens M, Kuypers DR, Vanrenterghem Y, Van Damme B. Lerut E, et al. Among authors: vanrenterghem y. Transplantation. 2007 Jun 15;83(11):1416-22. doi: 10.1097/01.tp.0000266676.10550.70. Transplantation. 2007. PMID: 17565313

8

The impact of renal allograft function on exposure and elimination of mycophenolic acid (MPA) and its metabolite MPA 7-O-glucuronide.

Naesens M, de Loor H, Vanrenterghem Y, Kuypers DR. Naesens M, et al. Among authors: vanrenterghem y. Transplantation. 2007 Aug 15;84(3):362-73. doi: 10.1097/01.tp.0000276936.14041.6c. Transplantation. 2007. PMID: 17700162 Clinical Trial.

9

Tacrolimus dose requirements and CYP3A5 genotype and the development of calcineurin inhibitor-associated nephrotoxicity in renal allograft recipients.

Kuypers DR, Naesens M, de Jonge H, Lerut E, Verbeke K, Vanrenterghem Y. Kuypers DR, et al. Among authors: vanrenterghem y. Ther Drug Monit. 2010 Aug;32(4):394-404. doi: 10.1097/FTD.0b013e3181e06818. Ther Drug Monit. 2010. PMID: 20526235

10

Reduced C0 concentrations and increased dose requirements in renal allograft recipients converted to the novel once-daily tacrolimus formulation.

de Jonge H, Kuypers DR, Verbeke K, Vanrenterghem Y. de Jonge H, et al. Among authors: vanrenterghem y. Transplantation. 2010 Sep 15;90(5):523-9. doi: 10.1097/TP.0b013e3181e9feda. Transplantation. 2010. PMID: 20592652

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

368 results

Search Page

Filters